These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1562019

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S, Westwick J, Kakkar VV.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Abnormal platelet response to thromboxane A2.
    Wu KK, Le Breton GC, Tai HH, Chen YC.
    J Clin Invest; 1981 Jun 01; 67(6):1801-4. PubMed ID: 6263954
    [Abstract] [Full Text] [Related]

  • 28. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL, Rand ML, Barrow DV, Packham MA.
    Atherosclerosis; 1991 May 01; 88(1):77-86. PubMed ID: 1878012
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK, Rao AK, Willis J, Colman RW.
    Proc Natl Acad Sci U S A; 1983 Oct 01; 80(19):6086-90. PubMed ID: 6577468
    [Abstract] [Full Text] [Related]

  • 30. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.
    J Lab Clin Med; 1989 May 01; 113(5):549-60. PubMed ID: 2541212
    [Abstract] [Full Text] [Related]

  • 31. Total and selective desensitisation of human platelets to synthetic platelet activating factor (PAF): evidence that extracellular PAF does not mediate collagen-induced aggregation.
    Nunn B.
    Thromb Res; 1983 Sep 01; 31(5):657-63. PubMed ID: 6648898
    [Abstract] [Full Text] [Related]

  • 32. Platelet activating factor stimulates cyclo-oxygenase activity in guinea pig eosinophils. Concerted biosynthesis of thromboxane A2 and E-series prostaglandins.
    Giembycz MA, Kroegel C, Barnes PJ.
    J Immunol; 1990 May 01; 144(9):3489-97. PubMed ID: 2158510
    [Abstract] [Full Text] [Related]

  • 33. Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity.
    Fuse I, Hattori A, Mito M, Higuchi W, Yahata K, Shibata A, Aizawa Y.
    Thromb Haemost; 1996 Dec 01; 76(6):1080-5. PubMed ID: 8972034
    [Abstract] [Full Text] [Related]

  • 34. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G, Stewart AG.
    Br J Pharmacol; 1991 Sep 01; 104(1):171-7. PubMed ID: 1664761
    [Abstract] [Full Text] [Related]

  • 35. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM, Wu TS, Teng CM.
    Br J Pharmacol; 1994 Mar 01; 111(3):906-12. PubMed ID: 8019768
    [Abstract] [Full Text] [Related]

  • 36. Vascular responses of platelet-activating factor in the Cebus apella primate and inhibitory profiles of antagonists SRI 63-072 and SRI 63-119.
    Handley DA, Van Valen RG, Saunders RN.
    Immunopharmacology; 1986 Jun 01; 11(3):175-82. PubMed ID: 3733419
    [Abstract] [Full Text] [Related]

  • 37. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M, Le Couedic JP, Vargaftig BB, Benveniste J.
    Br J Haematol; 1980 Nov 01; 46(3):455-64. PubMed ID: 6778498
    [Abstract] [Full Text] [Related]

  • 38. The role of inhibition of nitric oxide synthesis in the aggregation of platelets due to the stimulated production of thromboxane A2.
    Banerjee D, Mazumder S, Sinha AK.
    Blood Coagul Fibrinolysis; 2014 Sep 01; 25(6):585-91. PubMed ID: 25083729
    [Abstract] [Full Text] [Related]

  • 39. Effects of tetrandrine on rabbit platelet aggregation and platelet activating factor generation.
    Zhang M, Zhang LZ, Lu JS.
    Zhongguo Yao Li Xue Bao; 1995 May 01; 16(3):209-12. PubMed ID: 7660812
    [Abstract] [Full Text] [Related]

  • 40. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
    Hardisty RM, Machin SJ, Nokes TJ, Rink TJ, Smith SW.
    Br J Haematol; 1983 Apr 01; 53(4):543-57. PubMed ID: 6830700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.